Drug
Bacitracin Zinc, Neomycin Sulfate, Polymyxin B Sulfate
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Oral Candidiasis | 12 | 12.0 | 12.1 | signal |
| 2 | Respiratory Tract Congestion | 11 | 9.0 | 9.1 | signal |
| 3 | Anosmia | 9 | 8.1 | 8.1 | signal |
| 4 | Tooth Abscess | 6 | 7.6 | 7.7 | signal |
| 5 | Pharyngitis | 7 | 7.3 | 7.3 | signal |
| 6 | Drug Exposure During Pregnancy | 19 | 7.2 | 7.2 | signal |
| 7 | Drug Administration Error | 17 | 7.1 | 7.2 | signal |
| 8 | Anorexia | 7 | 7.0 | 7.0 | signal |
| 9 | Pharmaceutical Product Complaint | 14 | 6.9 | 7.0 | signal |
| 10 | Incorrect Drug Administration Duration | 15 | 6.8 | 6.9 | signal |
| 11 | Bronchitis | 38 | 6.7 | 6.8 | signal |
| 12 | Unintended Pregnancy | 5 | 6.2 | 6.2 | signal |
| 13 | Menstruation Irregular | 12 | 5.9 | 5.9 | signal |
| 14 | Tachypnoea | 6 | 5.8 | 5.8 | signal |
| 15 | Personality Change | 4 | 5.6 | 5.6 | signal |
| 16 | Intentional Drug Misuse | 9 | 5.5 | 5.6 | signal |
| 17 | Acne | 32 | 5.5 | 5.6 | signal |
| 18 | Stevens-johnson Syndrome | 9 | 5.3 | 5.3 | signal |
| 19 | Multi-organ Failure | 7 | 5.2 | 5.2 | signal |
| 20 | Dry Throat | 4 | 5.1 | 5.1 | signal |
| 21 | Lung Infection | 6 | 5.0 | 5.0 | signal |
| 22 | Thinking Abnormal | 7 | 4.9 | 4.9 | signal |
| 23 | Drug Toxicity | 5 | 4.7 | 4.7 | signal |
| 24 | Aphonia | 5 | 4.7 | 4.7 | signal |
| 25 | Sneezing | 8 | 4.7 | 4.7 | signal |
| 26 | Crying | 13 | 4.6 | 4.7 | signal |
| 27 | Heart Rate Irregular | 8 | 4.6 | 4.6 | signal |
| 28 | Local Swelling | 6 | 4.4 | 4.4 | signal |
| 29 | Pain Of Skin | 9 | 4.3 | 4.4 | signal |
| 30 | Application Site Irritation | 4 | 4.2 | 4.2 | signal |
| 31 | Ageusia | 8 | 4.2 | 4.2 | signal |
| 32 | Decreased Immune Responsiveness | 3 | 4.0 | 4.0 | signal |
| 33 | Skin Irritation | 14 | 4.0 | 4.0 | signal |
| 34 | Rash Generalised | 8 | 4.0 | 4.0 | signal |
| 35 | Psychomotor Hyperactivity | 5 | 3.9 | 3.9 | signal |
| 36 | Metrorrhagia | 5 | 3.8 | 3.8 | signal |
| 37 | Product Quality Issue | 38 | 3.7 | 3.7 | signal |
| 38 | Impaired Driving Ability | 3 | 3.4 | 3.4 | no signal |
| 39 | Gastric Disorder | 9 | 3.4 | 3.4 | signal |
| 40 | Abnormal Behaviour | 10 | 3.3 | 3.3 | signal |
| 41 | Muscle Spasticity | 3 | 3.1 | 3.2 | no signal |
| 42 | Abasia | 6 | 3.1 | 3.1 | signal |
| 43 | Abnormal Dreams | 6 | 2.8 | 2.8 | signal |
| 44 | Pregnancy | 4 | 2.6 | 2.6 | no signal |
| 45 | Wrong Technique In Drug Usage Process | 7 | 2.5 | 2.5 | signal |
| 46 | Skin Burning Sensation | 13 | 2.4 | 2.4 | signal |
| 47 | Inappropriate Schedule Of Drug Administration | 12 | 2.2 | 2.2 | signal |
| 48 | Premature Baby | 5 | 2.2 | 2.2 | no signal |
| 49 | Vaginal Haemorrhage | 7 | 2.1 | 2.1 | no signal |
| 50 | Drug Prescribing Error | 3 | 2.0 | 2.0 | no signal |
| 51 | Application Site Erythema | 4 | 2.0 | 2.0 | no signal |
| 52 | Drug Dose Omission | 24 | 1.9 | 1.9 | no signal |
| 53 | Application Site Pruritus | 3 | 1.7 | 1.7 | no signal |
| 54 | Extrapyramidal Disorder | 3 | 1.6 | 1.6 | no signal |
| 55 | Tardive Dyskinesia | 3 | 1.4 | 1.4 | no signal |